Anil Kapur - Oct 15, 2024 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Anil Kapur
Stock symbol
NRIX
Transactions as of
Oct 15, 2024
Transactions value $
$0
Form type
4
Date filed
10/16/2024, 04:48 PM
Previous filing
Jun 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Director Stock Option (right to buy) Award $0 +50K $0.00 50K Oct 15, 2024 Common Stock 50K $24.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/36 of the total shares monthly beginning November 15, 2024, until the option is fully vested on October 15, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.